Stock vs Stock Comparison

Alcon Inc. vs AbCellera Biologics Inc.

ALC and ABCL are evenly matched across key metrics.

ALC
ABCL

🏆 Tale of the Tape

22
ALCABCL
9.4%Profitability (Net Margin)-194.9%
3.8%Efficiency (ROIC)-12.4%
4/9Health (Piotroski F)4/9
4.9%Growth (Rev YoY)160.6%
Balance Sheet (D/E)0.40x

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricALCABCL
Market Cap
P/E Ratio
Forward P/E
P/B
Dividend Yield
Beta

Quantitative Metrics

MetricALCABCL
DCF Fair Value$113.71
DCF Upside
Piotroski F4/94/9
Altman Z
Beneish M
FCF Yield
Net Debt/EBITDA
ROIC3.8%-12.4%
WACC
ROIC – WACC
Gross Margin55.2%
Net Margin9.4%-194.9%
Rev Growth YoY4.9%160.6%
Sharpe (1Y)
Max Drawdown 3Y
FCF Payout Ratio10%

ALC Price

Loading chart...

ABCL Price

Loading chart...

ETF Exposure

ALC found in:

VGK0.24%
VSGX0.13%
VEA0.12%
SPDW0.10%
CWI0.10%
VEU0.09%
VXUS0.08%
VT0.03%

ABCL found in:

GWX0.09%
SPDW0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ALC vs ABCL: Head-to-Head Analysis

Alcon Inc. (ALC) and AbCellera Biologics Inc. (ABCL) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, ALC generates a return on invested capital (ROIC) of 3.8% compared to ABCL's -12.4%. This suggests ALC is more effective at deploying capital to generate shareholder returns.

ALC appears in 8 ETFs tracked by SecuritiesDB, while ABCL appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ALC or ABCL?

Our quantitative analysis compares ALC and ABCL across nine fundamental dimensions. ALC and ABCL are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ALC and ABCL correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.